Relevant bibliographies by topics / Schizophrenics Treatment

Academic literature on the topic 'Schizophrenics Treatment'

Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Schizophrenics Treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Schizophrenics Treatment"

1

Vandamme, Michel J., and Jean-Louis Nandrino. "Temperament and Character Inventory in Homicidal, Nonaddicted Paranoid Schizophrenic Patients: A Preliminary Study." Psychological Reports 95, no. 2 (October 2004): 393–406. http://dx.doi.org/10.2466/pr0.95.2.393-406.

Full text
Abstract:
This study assessed the personalities of 13 murderer schizophrenics using Cloninger's Temperament and Character Inventory, controlling different factors such as institution, treatment, detention or loss of liberty, and can discriminate between schizophrenic patients involved in homicide, schizophrenics with no past violent behavior, paranoiac murderers, and imprisoned murderers with no psychiatric history. Results show significantly that murderer schizophrenics had significantly higher scores on the subscale, Self-transcendence, than other groups, which suggests that Self-transcendence as measured may be an aggravating factor for schizophrenia and may be found in the personality of schizophrenic subjects who performed homicidal acts. This dimension constitutes a way and an additional element for diagnosis not available with the DSM–IV criteria. It may help understanding and predicting violent behavior among schizophrenic patients.
APA, Harvard, Vancouver, ISO, and other styles
2

Ozeki, Tomoe, Tetsuya Mouri, Hiroko Sugiura, Yuu Yano, and Kunie Miyosawa. "Impression Survey and Grounded Theory Analysis of the Development of Medication Support Robots for Patients with Schizophrenia." Journal of Robotics and Mechatronics 33, no. 4 (August 20, 2021): 747–55. http://dx.doi.org/10.20965/jrm.2021.p0747.

Full text
Abstract:
Medication is a key treatment for patients with schizophrenia. Patients with schizophrenia tend to easily decrease medication adherence with long-term treatment. However, there is a chronic shortage of specialists who provide medication support, such as visiting nurses. In addition, these patients do not often use smartphones or PCs in their daily lives. Thus, schizophrenic patients need a direct approach in the physical world because they are unfamiliar with cyberspace. This study aims to improve the home treatment environment using robot technology that can approach in the physical world of schizophrenic patients who need medication support. In this study, collaboration between psychiatric nursing specialists and medical engineers investigated the interaction between communication robots and patients. The results showed that the robot was accepted by patients with schizophrenia as a talking partner. The amount of robot talking seemed to affect the impression of the robot on schizophrenics. Utterance process analysis showed that the smoothness of the conversation affected the relationship between robots and schizophrenics.
APA, Harvard, Vancouver, ISO, and other styles
3

Espina, Alberto, Asunción Ortego, Iñigo Ochoa de Alda, and Pilar González. "Dyadic adjustment in parents of schizophrenics." European Psychiatry 18, no. 5 (August 2003): 233–40. http://dx.doi.org/10.1016/s0924-9338(03)00063-4.

Full text
Abstract:
AbstractObjectiveTo study the dyadic adjustment in couples with a schizophrenic offspring.Method140 married couples, 67 with a children with schizophrenia, and two control groups: 41 couples without pathology and 32 couples with pathology, were assessed with the Dyadic Adjustment Scale, the Beck Depression Inventory and the Self-Rating Anxiety Scale.ResultsThe couples with a schizophrenic offspring evidenced significantly worse dyadic adjustment than did the normal controls, especially low consensus and cohesion in husbands, and low cohesion and satisfaction in wives. Anxiety and depression in mothers of schizophrenics is significantly higher than in mothers of controls.DiscussionThese findings suggest that the poor dyadic adjustment of the parents with a schizophrenic offspring could be an effect of the burden.ConclusionThe treatment on the schizophrenia should be supplemented by interventions aimed at parents’ dyadic adjustment, and mothers’ anxiety and depression, so that they can be in better conditions to help their child.
APA, Harvard, Vancouver, ISO, and other styles
4

Soyka, Michael, Sebastian Dittert, Martin Schäfer, Andreas Gartenmaier, Gerd Laux, Catja Winter, and Hans-Jürgen Möller. "Psychomotor Performance Under Neuroleptic Treatment in Schizophrenia." Zeitschrift für Neuropsychologie 12, no. 1 (February 2001): 49–53. http://dx.doi.org/10.1024//1016-264x.12.1.49.

Full text
Abstract:
Abstract: Cognitive dysfunction has been recognized as an important clinical feature of schizophrenia. The possible pharmacological effect of neuroleptics on cognitive and psychomotor function including driving ability is crucial for rehabilitation of schizophrenic patients. Atypical neuroleptics such as risperidone have been shown to improve cognitive deficits in schizophrenics. We conducted a naturalistic nonrandomized clinical study to determine the effect of risperidone on psychomotor function compared to haloperidol in schizophrenic patients. In this study the psychomotor performance of 26 patients, who met the ICD-10 and DSM-IV criteria for schizophrenia, was assessed by means of ART-90, a computer-based Act & React Testsystem. 11 patients were on risperidone (mean dosage 4.0 mg) and 15 patients on haloperidol (mean dosage 10.5 mg). Patients were examined at discharge after psychopathological stabilization. In some relevant items the patients in the haloperidol group showed more impaired performance compared to the patients in the risperidone group. These preliminary data indicate a possible beneficial effect of risperidone compared to haloperidol on psychomotor performance and driving ability. Further randomized trials are necessary.
APA, Harvard, Vancouver, ISO, and other styles
5

Bird, J. M. "Computed Tomographic Brain Studies and Treatment Response in Schizophrenia." Canadian Journal of Psychiatry 30, no. 4 (June 1985): 251–54. http://dx.doi.org/10.1177/070674378503000407.

Full text
Abstract:
Ventricular enlargement has been described in chronic schizophrenia since 1927. The CT Scan has stimulated considerable interest and studies have shown that 50% of chronic schizophrenics and up to 20% of acute schizophrenics have enlarged ventricles. Widening of cortical sulci, cerebellar atrophy, third ventricular enlargement and reversed hemispheric assymetry have also been reported. Ventricular enlargement seems to both predate the development of psychosis and to develop further during the course of the illness. Twin studies indicate that ventricular enlargement may be the result both of genetic vulnerability and of environmental onslaught. The other abnormalities may be secondary. Schizophrenics without ventricular enlargement show disturbances of a range of Dopamine-related variables. Schizophrenics with ventricular enlargement show some evidence of serotonin and noradrenaline cell loss. Very few published papers address the issue of treatment response. These seem to demonstrate a relationship between enlargement and poor response to neuroleptic medication. Schizophrenics with very large ventricles may also be particularly sensitive to the adverse effects of neuroleptics. It is not yet clear that the CT Scan may be used to identify patients unlikely to respond to medication. Long term prospective studies are required.
APA, Harvard, Vancouver, ISO, and other styles
6

Erkwoh, R., M. Schreckenberger, U. Cremerius, A. Owega, C. Diekmann, G. Schulz, M. Zimny, H. Sass, U. Buell, and O. Sabri. "Altered Relationships Between rCBF in Different Brain Regions of Never-Treated Schizophrenics." Nuklearmedizin 36, no. 06 (1997): 194–201. http://dx.doi.org/10.1055/s-0038-1629739.

Full text
Abstract:
Summary Aim of this study was to investigate the relations between regiona cerebral blood flow (rCBF) of different brain regions in acute schizophrenia and following neuroleptic treatment. Methods: Twenty-two never-treated, acute schizophrenic patients were examined with HMPAO brain SPECT and assessed psychopathological-ly, and reexamined following neuroleptic treatment (over 96.8 days) and psychopathological remission. rCBF was determined by region/cerebel-lar count quotients obtained from 98 irregular regions of interest (ROIs), summed up to 11 ROIs on each hemisphere. In acute schizophrenics, interregional rCBF correlations of each ROI to every other ROI were compared to the interregional correlations following neuroleptic treatment and to those of controls. Results: All significant correlations of rCBF ratios of different brain regions were exclusively positive in controls and patients. In controls, all ROIs of one hemisphere except the mesial temporal ROI correlated significantly to its contralateral ROI. Each hemisphere showed significant frontal-temporal correlations, as well as cortical-subcortical and some cortico-limbic. In contrast, in acute schizophrenics nearly every ROI correlated significantly with every other ROI, without a grouping or relation of the rCBF of certain ROIs as in controls. After neuroleptic treatment and clinical improvement, this diffuse pattern of correlations remained. Conclusions: These results indicate differences in the neuronal interplay between regions in schizophrenic and healthy subjects. In never-treated schizophrenics, diffuse interregional rCBF correlations can be seen as a sign of change and dysfunction of the systems regulating specificity and diversity of the neuronal functions. Neuroleptic therapy and psychopathologic remission showed no normalizing effect on interregional correlations.
APA, Harvard, Vancouver, ISO, and other styles
7

Addington, Donald, and Heather L. Holley. "A Comparison of Voluntary with Remanded Schizophrenics." Canadian Journal of Psychiatry 34, no. 2 (March 1989): 89–93. http://dx.doi.org/10.1177/070674378903400203.

Full text
Abstract:
In this study two groups of schizophrenic patients are compared on a number of clinical and demographic variables. The first group consists of 52 consecutive admissions to a forensic assessment unit of patients with a diagnosis of schizophrenia. The second is a consectutive series of schizophrenic patients admitted to two open admission units. Significant differences were found between the two groups. Specifically the forensic patients were more often male, single and antisocial as assessed by previous convictions and more often transient or living semi-independently in sheltered accommodation. They were less compliant with treatment. The two groups did not differ with respect to clinical features such as duration of illness and number of hospitalizations. It is concluded that individual patient characteristics may contribute to an outcome of legal involvement among schizophrenics. The implications of this for service delivery and future research on criminalization are discussed.
APA, Harvard, Vancouver, ISO, and other styles
8

Warren, Jerry. "Psychological and Social Integration for Those Labeled Schizophrenic." Psychological Reports 58, no. 1 (February 1986): 243–46. http://dx.doi.org/10.2466/pr0.1986.58.1.243.

Full text
Abstract:
The scope and etiology of schizophrenia, the negative effects of neuroleptic treatment and involuntary hospitalization, and the lack of psychosocial rehabilitation services in the United States are noted. Self-help communes for former mental patients in Denmark and Germany are briefly described as providing a communal therapy through group meetings and daily communal life that apparently leads to psychological and social integration of individuals previously labeled schizophrenic. The development of similar communes for chronic schizophrenics is proposed for the United States.
APA, Harvard, Vancouver, ISO, and other styles
9

Tang, S. W. "Prediction of Treatment Response in Schizophrenia: Clinical Use of Neuroleptic Blood Levels." Canadian Journal of Psychiatry 30, no. 4 (June 1985): 249–50. http://dx.doi.org/10.1177/070674378503000406.

Full text
Abstract:
The relationship between clinical response and plasma neuroleptic levels in schizophrenia is unclear. A part from the inadequacy of the plasma neuroleptic assay method, resistance to neuroleptic treatment in some schizophrenics presents a serious problem in studies looking into the plasma drug level versus clinical response correlation. Previous studies have suggested a very wide range of plasma neuroleptic levels in responders. At present, plasma neuroleptic level does not predict clinical response in schizophrenics in general, but may have application in special situations such as suspected drug toxicity, neuroleptic resistance or idiosyncratic response to neuroleptic drugs.
APA, Harvard, Vancouver, ISO, and other styles
10

Smith, Jeanette, Faye Grant, and Phil Brinded. "Schizophrenics Remanded to the Forensic Psychiatric Institute of British Columbia, 1975–1990." Medicine, Science and the Law 34, no. 3 (July 1994): 221–26. http://dx.doi.org/10.1177/002580249403400306.

Full text
Abstract:
Clinical and legal data were collected on 1265 schizophrenic patients remanded to a maximum security hospital, for psychiatric evaluation of fitness to stand trial. Schizophrenics accounted for over half of the remand population. When compared to the non-schizophrenic group, they had more previous admissions to the Forensic Psychiatric Institute and the Provincial Mental Hospital. They were also more likely to be found unfit to stand trial or to have their charges stayed by the Crown. However, approximately half of the schizophrenics in this study returned to Court, fit to stand trial and with no further psychiatric treatment provided. This study raises major questions about the purpose and value of remanding schizophrenics to a maximum security hospital for in-patient fitness evaluations.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Schizophrenics Treatment"

1

Marschinke, Kathleen. "Family interventions in the treatment of schizophrenia." Online version, 1999. http://www.uwstout.edu/lib/thesis/1999/1999marschinkek.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Franco, Michelle E. "A behavioral treatment program for chronic schizophrenics." Scholarly Commons, 1997. https://scholarlycommons.pacific.edu/uop_etds/2305.

Full text
Abstract:
I examined the effects of a residential treatment program on symptoms and mental health service use in 14 chronic schizophrenics. The clients chosen for this study were the most difficult clients in this population due to continued high service usage (i.e., time spent in locked facilities). All 14 clients had been in a locked facility at least 1 year immediately prior to treatment. The program included skills training, reinforcement for incompatible behavior, and a token economy. The clients' symptomology was recorded twice a day. My hypotheses were that symptoms would decrease due to the program, and clients mental health service use would also decrease in a 1 year follow-up. Mental health service use (time spent in a locked facility) did decrease dramatically after treatment. All 14 clients had a decrease in the amount of time spent in locked facilities after treatment. The total cost for these clients in locked facilities the year immediately prior to treatment was conservatively estimated at $776,500. The annualized figure of the total cost of these 14 clients after treatment was estimated at $44,775, saving San Joaquin County approximately $721,725 in 1 year. The results did not support the hypothesis that the program reliably decreases schizophrenic symptomology as we measured it.
APA, Harvard, Vancouver, ISO, and other styles
3

Schock, Sandra Lynn. "Difficulties in psychotherapy with a residual schizophrenic." Thesis, Rhodes University, 1991. http://hdl.handle.net/10962/d1007457.

Full text
Abstract:
This work addresses some of the difficulties encountered while working in psychotherapy with a residual schizophrenic. While there is an abundance of literature on psychotherapy for schizophrenia, both supporting and also refuting its merit, what the literature fails to reveal is that there appears to be a class of schizophrenic who, while apsychotic and able to communicate in the everyday sense of the word, is in a psychic space which speaks of a break with the basic relational elements of the human order. The quality of the patient's psychic life is such that almost nothing of what the literature describes as useful and appropriate in working with schizophrenics seems to help in the psychotherapeutic work with this type of patient. This study describes these issues with relevance to a particular residual schizophrenic. The Illustrative-didactic case-study method was used to discuss the four-and- a-half month psychotherapy with this patient. The patient's early developmental history, premorbid personality functioning, family and interpersonal relationships, mental state, diagnosis and a rationale for psychotherapy were presented and considered in detail. The structure of the psychotherapeutic process was reviewed in depth. The hermeneutic guidelines to understanding the case were drawn from Object-Relations Psychoanalytic theory, particularly Balint, Khan, Karon & VandenBos, Bollas, Romanyshyn, Perry, Symington, Fordham and others. Various psychic and personality features, as unveiled through the psychotherapeutic process, were elaborated and the implications of these for the therapeutic endeavour were considered as follows: Firstly, the psychic space of the patient, which precluded mirroring, symbolization find object-relationship - and which made psychotherapy untenable, was discussed. Secondly, therapeutic ambivalence and other counter-transference issues were reviewed. Thirdly, the shadow sides of both therapeutic optimism and of psychotherapeutic change were considered. Fourthly, the issues of therapeutic failure and of other treatment possibilities for a residual schizophrenic patient were examined. It was concluded that there needs to be an important countertransference shift with regard to the psychotherapeutic goals for those patients whose condition may be chronic, and for whom it appears that psychotherapy is not going to be of any therapeutic benefit - find where an 'empathic accompaniment' might be as much as it is possible to hope for or achieve.
APA, Harvard, Vancouver, ISO, and other styles
4

Green, Asha M. "Participant Perspectives: Investigating the Experience of Low-Income Schizophrenics in Clinical Research Trials." Thesis, University of North Texas, 2015. https://digital.library.unt.edu/ark:/67531/metadc799519/.

Full text
Abstract:
The continued investigation into the experiences of individuals with schizophrenia who participate in biomedical research trials is necessary in order to understand participants’ perspectives, motivations, attitudes, values, and beliefs. As important stakeholders in the clinical research process, participant feedback is significant and can help shed light on, not only their experiences, but also deepen understandings when it comes to clinical trial participants’ perceptions of informed consent and personal autonomy. Conducting ethical research demands the exploration of these issues and specifically targeting this vulnerable group helped to address a gap in the literature. This study was conducted for InSite Clinical Research and gathered data in the form of in-depth semi-structured interviews and a short survey instrument with 20 low-income adults diagnosed with schizophrenia that participate in clinical research trials. Findings indicate overall positive research experiences, with motivations aligning with previous research when it comes to trial participation including: altruism, personal benefit, access to medications, financial incentives, and psychosocial treatment. Learning about their illness and themselves, autonomy, and debriefing were also particularly important within this group. Unique to this sample were findings of friendship. Trust in the research staff was identified as a major underlying value and shaping factor impacting informed consent decisions. These conclusions have implications for recruitment and informed consent practices at InSite Clinical Research.
APA, Harvard, Vancouver, ISO, and other styles
5

Chun, Wai Kwong. "Voice hearing among Chinese people with schizophrenia in Hong Kong." HKBU Institutional Repository, 2009. http://repository.hkbu.edu.hk/etd_ra/985.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Conner, Dianna Holden. "Social skills training for individuals with schizophrenia: Evaluation of treatment outcome and acquisition of social and cognitive skills." Thesis, University of North Texas, 2004. https://digital.library.unt.edu/ark:/67531/metadc4713/.

Full text
Abstract:
Social and cognitive skill acquisition were evaluated in 33 (male=24, female=11) outpatients with schizophrenia or schizoaffective disorder. A social skills training treatment group (n=19) was compared to a wait-list control (n=14). Participants' mean age was 41 years, mean number of hospitalizations 10.4, and mean number of years with diagnosis 15.8. Assessment measures included WAIS-III Picture Arrangement subtest, Social Cue Recognition Test, COGLAB, WMS-III Word List subtest, and SADS-C. Results did not support the main hypotheses of improved social and cognitive skills in the treatment group. Participants with better memory and attention at pre-testing also did not show an advantage in social skills improvement. Contrary to hypotheses, the control group improved the most on some social and cognitive measures. Several supplemental hypotheses yielded the following results: lack of volunteer participation from paranoid schizophrenia individuals; evidence that schizoaffective disorder participants may be less cognitively impaired and better able to benefit from social skills training; and younger, less chronic participants with better attentional capacities may benefit most from social skills training. Findings are discussed in light of the possibility that improving social skills might not improve social and cognitive functioning, at least with the dosage of social skills training provided in this study. Limitations such as a sampling bias and small study size are also considered as possible explanations for the pattern of findings. Clinical and research implications are discussed to apply and extend the current findings.
APA, Harvard, Vancouver, ISO, and other styles
7

Theron, Janina. "Pragmatic assessment of schizophrenic bilinguals' L1 and L2 use : a comparison of three assessment tools." Thesis, Stellenbosch : University of Stellenbosch, 2009. http://hdl.handle.net/10019.1/1783.

Full text
Abstract:
Thesis (MPhil (General Linguistics))—University of Stellenbosch, 2009.
ENGLISH ABSTRACT: The term "schizophrenia" refers to a psychiatric condition which affects an individual's thought and speech (Eaton and Chen 2006). The verbal expression of schizophrenics can therefore be used as a tool for insight into the nature of schizophrenia as well as the cognitive processes of schizophrenics (Wróbel 1990:1). This thesis reports on a comparative evaluation of three pragmatic assessment tools, namely the Pragmatic Protocol (Prutting and Kirchner 1987), the Profile of Communicative Appropriateness (Penn 1985), and the Framework for Assessing (Children's) Conversational Skills (Rumble 1988), in order to establish which of these tools is most suitable for assessing the first language (L1) and second language (L2) pragmatic abilities of late bilingual schizophrenics. Four late bilingual schizophrenic patients participated in this study. A thirty minute informal interview was conducted with each of the participants in both their L1 and L2 and the speech samples were transcribed and then analysed by means of each of the pragmatic assessment tools. A careful examination of the results yielded by the three assessment tools, showed, firstly, that when presenting the results of a pragmatic assessment of schizophrenic speech, it is crucial that both quantitative and qualitative information be included: if the latter is excluded, a significant amount of information is hidden from the clinicians and/or linguists doing the assessment, as well as the people to whom they report their findings. Secondly, with respect to the characteristics of schizophrenic speech, the three instruments used in this study show that whereas most of the aspects of schizophrenics' linguistic abilities seem intact, their pragmatic skills are definitely impaired. Thirdly, regarding differential symptomatology in bilingual schizophrenics, this study concludes that none of the three assessment tools contributes to a better understanding of this phenomenon, and that, in fact, it is highly unlikely that any pragmatic assessment tool would be able to capture this phenomenon. Finally, it is recommended that clinicians assess bilingual patients in both languages, whenever possible, in order to determine the full range of symptoms experienced by the patient, to gain a better indication of the severity of the illness and to track the progress of the illness.
AFRIKAANS OPSOMMING: Die term "skisofrenie" verwys na 'n psigiatriese toestand wat 'n individu se denkprosesse en spraak beïnvloed (Eaton en Chen 2006). Die verbale uitinge van skisofrene kan dus gebruik word om insig oor die aard van skisofrenie, sowel as die kognitiewe prosesse van skisofrene, te verkry (Wróbel 1990:1). Hierdie tesis lewer verslag oor 'n vergelykende evaluering van drie pragmatiese assesseringsinstrumente, naamlik die "Pragmatic Protocol" (Prutting en Kirchner 1987), die "Profile of Communicative Appropriateness" (Penn 1985), en die "Framework for Assessing (Children's) Conversational Skills" (Rumble 1988), om sodoende vas te stel watter een van hierdie drie die mees gepaste instrument is vir die assessering van tweetalige skisofrene se pragmatiese vaardighede in hul eerstetaal (T1) en tweedetaal (T2), spesifiek in gevalle waar die T2 later (d.w.s. nie binne die eerste sewe lewensjare nie) verwerf is. Vier sulke tweetalige skisofrene het deelgeneem aan die studie. Daar is met elkeen van die deelnemers 'n informele onderhoud gevoer vir 30 minute in hul T1, gevolg deur 30 minute in hul T2. Die onderhoude is getranskribeer en daarna geanaliseer deur middel van elk van die drie assesseringsinstrumente. 'n Noukeurige ondersoek en vergelyking van die resultate van die drie instrumente het eerstens getoon dat dit belangrik is om die resultate van 'n pragmatiese analise van skisofreniese spraak op beide 'n kwantitatiewe en kwalitatiewe wyse aan te bied: wanneer kwalitatiewe inligting weggelaat word, bly 'n betekenisvolle hoeveelheid van die informasie verborge vir die klinici en/of taalwetenskaplikes wat die assessering doen, asook die mense aan wie hulle hulle bevindinge rapporteer. Tweedens, met betrekking tot die eienskappe van skisofreniese spraak, wys die drie instrumente wat in hierdie studie gebruik is dat alhoewel meeste aspekte van skisofrene se taalvaardighede ongeskonde is, hulle pragmatiese vaardighede ooglopend aangetas is. Derdens, rakende differensiële simptomatologie in tweetalige skisofrene kom hierdie studie tot die gevolgtrekking dat geen van die drie instrumente bydra tot 'n beter begrip van hierdie verskynsel nie, en dat dit selfs hoogs onwaarskynlik is dat enige pragmatiese assesseringsinstrument hierdie verskynsel sou kon vaslê. Uiteindelik word daar aanbeveel dat klinici, wanneer dit ookal moontlik is, tweetalige pasiënte in beide tale behoort te assesseer om sodoende die volledige reeks van simptome wat 'n pasiënt ervaar vas te stel, om 'n beter aanduiding te bekom oor die erns van die siekte, en om die progressie van die siekte te volg.
APA, Harvard, Vancouver, ISO, and other styles
8

Steinberg, Marc L. 1971. "Engaging smokers with schizophrenia in treatment for tobacco dependence [electronic resource] : a brief motivational interviewing intervention / by Marc L. Steinberg." University of South Florida, 2003. http://purl.fcla.edu/fcla/etd/SFE0000075.

Full text
Abstract:
Includes vita.
Title from PDF of title page.
Document formatted into pages; contains 114 pages.
Thesis (Ph.D.)--University of South Florida, 2003.
Includes bibliographical references.
Text (Electronic thesis) in PDF format.
ABSTRACT: The purpose of this study was to determine how to best motivate smokers with schizophrenia or schizoaffective disorder to seek treatment for tobacco dependence. Smokers with schizophrenia or schizoaffective disorder (N=78) were randomly assigned to receive a Motivational Interviewing, Psychoeducational, or Minimal Control intervention. A greater proportion of participants receiving the Motivational Interviewing intervention followed through on a referral for tobacco dependence treatment within one-week and one-month post-intervention. Mixed model Analyses of Variance found no differences between groups at one-week or at one-month with respect to tobacco use or motivation to quit. Within group analyses indicated that participants in the Motivational Interviewing and Psychoeducational groups reported significant decreases in cigarettes smoked per day.
ABSTRACT: Only participants in the Motivational Interviewing group showed significant increases in confidence in their ability to quit smoking.
System requirements: World Wide Web browser and PDF reader.
Mode of access: World Wide Web.
APA, Harvard, Vancouver, ISO, and other styles
9

Wills, Jack Blanton. "Effects of stress management instruction and anxiety monitoring in adult day treatment population." PDXScholar, 1986. https://pdxscholar.library.pdx.edu/open_access_etds/3698.

Full text
Abstract:
This study examines the effectiveness of a particular stress management intervention with adult outpatients diagnosed as chronic schizophrenics. The setting for the study was the Portland, Oregon, Veteran's Administration, Outpatient Clinic, Day Treatment Center. The intervention was composed of two factors; 1) stress management training and 2) Behavior-Graph Instruction. Both of these were presented using a psychoeducational model of classroom instruction, role play, and discussion.
APA, Harvard, Vancouver, ISO, and other styles
10

Eichelberger, James R. "A Christian counselor's experience in working with schizophrenics in the state hospital system and preliminary treatment suggestions." Theological Research Exchange Network (TREN), 2005. http://www.tren.com.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Schizophrenics Treatment"

1

1948-, Lieberman Jeffrey A., and Murray, Robin, MD, M Phil, MRCP, MRC Psych, eds. Comprehensive care of schizophrenia: A textbook of clinical management. London: Martin Dunitz, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

1936-, Breggin Peter Roger, and Stern E. Mark 1929-, eds. Psychosocial approaches to deeply disturbed persons. New York: Haworth Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Die Einbeziehung der Angehörigen in die Behandlung schizophrener Patienten und ihr Einfluss auf den Krankheitsverlauf. Frankfurt am Main: P. Lang, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Okezie, Ngozi Babette. Sociocultural variables in the diagnosis of schizophrenia among inpatients. [s.l: s.n.], 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

1930-, Goldstein Michael J., Hand Iver, and Hahlweg Kurt, eds. Treatment of schizophrenia: Family assessment and intervention. Berlin: Springer-Verlag, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Diane, Gibson, ed. Treatment of the chronic schizophrenic patient. New York: Haworth Press, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bois, Reinmar Du. Junge Schizophrene zwischen Altag und Klinik: Altertypisches Erleben, Betreuungsforman und Weichenstellungen am Krankheitsbeginn : ein Leitfaden für Eltern und helfende Berufe. Göttingen: Hogrefe, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Schizophrenics can be good mothers too. London: Muswell Hill Press, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Psychologische Intervention bei den Angehörigen schizophrener Patienten. Frankfurt am Main: P. Lang, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Treating the "untreatable": Healing in the realms of madness. London: Karnac Books, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Schizophrenics Treatment"

1

Johnson, D. A. W. "The Complex Problem of Treatment." In Depression in Schizophrenics, 193–201. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4757-9978-1_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kelly, Jeffrey A., and Danuta M. Lamparski. "Outpatient Treatment of Schizophrenics." In Handbook of Clinical Behavior Therapy with Adults, 485–506. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4613-2427-0_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dulz, B., and I. Hand. "Short-Term Relapse in Young Schizophrenics: Can It Be Predicted and Affected by Family (CFI), Patient, and Treatment Variables? An Experimental Study." In Treatment of Schizophrenia, 59–77. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-95496-2_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Wistedt, Börje. "Effect of Neuroleptic Withdrawal during the Maintenance Treatment of Chronic Schizophrenics." In Psychiatry the State of the Art, 751–57. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4613-2363-1_117.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sherin, Jonathan E., and Stephen R. Marder. "Pharmacological Treatment." In Schizophrenia, 161–83. Chichester, UK: John Wiley & Sons, Ltd, 2011. http://dx.doi.org/10.1002/9780470978672.ch6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Silber, Kevin. "Biological Treatments." In Schizophrenia, 127–44. London: Macmillan Education UK, 2014. http://dx.doi.org/10.1007/978-1-137-44652-7_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Whitaker, Leighton C. "Treatment and Prevention." In Schizophrenic Disorders, 195–217. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4757-2159-1_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Haddock, Gillian, and Will Spaulding. "Psychological Treatment of Psychosis." In Schizophrenia, 666–86. Oxford, UK: Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444327298.ch32.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Marder, Stephen R. "Pharmacological treatment of schizophrenia." In Schizophrenia, 325–38. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4899-4457-3_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Brenner, H. D., S. Kraemer, M. Hermanutz, and B. Hodel. "Cognitive Treatment in Schizophrenia." In Schizophrenia, 161–91. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74308-5_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Schizophrenics Treatment"

1

Miclutia, Ioana Valentina, Laura Damian, and Ana Cristina Serban. "SEXUAL FUNCTIONING IN SCHIZOPHRENIC AND BIPOLAR FEMALE PATIENTS." In The European Conference of Psychiatry and Mental Health "Galatia". Archiv Euromedica, 2023. http://dx.doi.org/10.35630/2022/12/psy.ro.13.

Full text
Abstract:
Introduction: The issue of sexuality is seldom investigated by psychiatrists in psychotic psychiatric patients, partly due to the frontline distressing psychiatric and behavioural symptoms but also due to hesitancy, haste, reluctance. Even though, the aspects of intimacy, sexual functioning are important and bothering, especially for young patients. These sexual impairments might be attributed to the disease itself but also to the medication. Material and Methods: Two separate studies aim to investigate sexual disorders in female inpatient patients diagnosed with schizophrenia and in different phases of bipolar disorder (depression, manic) in comparison to controls. Therefore, treatment emergent sexual side effects (UKU scale), their relation to psychopathology (PANSS, GAF), quality of life (WHO-QOL Bref), misbelieves (Sexual Dysfunctional beliefs Questionnaire) were explored in chronic female schizophrenic patients and compared to matched controls. For the bipolar group, the depressed, manic women and controls were assessed regarding frequency of sexual intercourse, fantasies, desire, and lubrication orgasm by the Sexual Disorders Interview, Female Sexual Index and psychopathology by BDI, respectively YMRS. Both studies were cross-sectional and collected various demographical and therapeutical data. Results: Schizophrenic patients rendered long histories of the disease and treatments, cumulating also disturbing side effects such as weight gain, amenorrhea, less marital and sexual partners. Low sexual interest, modest initiative, involvement, absent orgasm and sexual conservatorism were common and constant during exacerbations but also in chronicity being in connection rather to negative symptoms and modest functioning. Regarding bipolar women, sexual problems were detected in over 75% of the cases, with less implication and satisfaction during depression, pain, often blaming antidepressants as probable source of dissatisfaction. On the other hand, manic patients display more vivid sexual fantasies and interest, with higher arousal and lubrication, attending sexual satisfaction but being disturbed subjectively by some of these aspects. Although a wide range of sexual disorders might arise after treatment with antipsychotics, antidepressants, mood stabilizers, there could not be clearly ascertained a specific disorder. Discussions: Hyposexuality seems to be a hallmark of schizophrenics even in treatment naïve patients, being more obvious after treatment, in chronicity. The issue of sexuality in bipolar women is rather difficult to assess and compare partly to the heterogeneity of the disorder. Conclusions: Sexual disorders are a special and frequent issue in schizophrenia and bipolar women, displaying a wide range from low frequency, interest, dissatisfaction or even pain and a temporary phase limited exacerbation of sexuality during manic episodes.
APA, Harvard, Vancouver, ISO, and other styles
2

"ARIPPRIPAZOLE AND ITS POTENTIAL EFFECT IN REDUCING COCAINE CRAVING IN SCHIZOPHRENIC PATIENTS WITH COCAINE-DEPENDENCE." In 23° Congreso de la Sociedad Española de Patología Dual (SEPD) 2021. SEPD, 2021. http://dx.doi.org/10.17579/sepd2021p062s.

Full text
Abstract:
Goals: Non-systematic literature review of the role of aripiprazole in alleviating cocaine craving in schizophrenic patients with cocaine-dependence (CD). Material and methods: From the review performed, 2 studies outstand: In one study, 6 schizophrenic patients with CD completed 8 weeks of treatment with aripiprazole at a maximum dose of 15 mg/d. The Brief Psychiatric Rating Scale and the Brief Substance Craving Scale (BSCS) were used to measure psychosis and subjective cocaine and alcohol cravings and urine tests for cocaine were performed. In another study, 44 CD patients with schizophrenia or schizoaffective disorder were treated with aripiprazole or perphenazine during 8 weeks. The perphenazine group received the recommended dosage not exceeding 24 mg/d and the patients receiving aripripazole were started on 15 mg/d to a maximum of 30 mg/d or a minimum of 10 mg/d. Primary outcome targeted cocaine-free urine sample proportions, whereas secondary outcome focused on cocaine craving scores. BSCS was used to assess cocaine craving and the positive and negative symptom scale and the clinical global impression scale were used to monitor psychotic symptom severities. Results and conclusion: In the first study, positive urine tests dropped significantly after 2 weeks, mean cocaine and acohol craving scores declined significantly, and declining psychosis scores were associated with declining cocaine and alcohol craving. In the second study, the proportion of negative drug test results did not differ significantly between patients treated with aripiprazol or perphenazine. Regarding the anticraving effect, in the aripiprazol group during week 3 to 8, significant reductions in craving intensity, frequency and duration were seen, while no similar reduction was seen with perphenazine. In conclusion, although the results are still limited, studies suggest that aripiprazol may have a potential effect in dual diagnosis patients with schizophrenia and CD, possibly due to its dopamine activity as a partial agonist/antagonist.
APA, Harvard, Vancouver, ISO, and other styles
3

Pan, Jingwen. "An overview of Schizophrenia treatment options." In 4TH INTERNATIONAL CONFERENCE ON FRONTIERS OF BIOLOGICAL SCIENCES AND ENGINEERING (FBSE 2021). AIP Publishing, 2022. http://dx.doi.org/10.1063/5.0094794.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ben-Yoav, Hadar, Matan aroosh, Rajendra Shukla, Yuly Bersudsky, and Deanna Kelly. "Intelligent Microelectrodes Array for Schizophrenia Treatment Monitoring." In 7th International Electronic Conference on Sensors and Applications. Basel, Switzerland: MDPI, 2020. http://dx.doi.org/10.3390/ecsa-7-08217.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

"Schizophrenia: Current Progress and New Treatment Perspective." In 2022 International Conference on Biotechnology, Life Science and Medical Engineering. Clausius Scientific Press, 2022. http://dx.doi.org/10.23977/blsme.2022044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

"O-007 - PRESCRIPTION PATTERNS ON PATIENTS WITH DUAL DIAGNOSIS: A RETROSPECTIVE INPATIENT ANALYSIS." In 24 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL. SEPD, 2022. http://dx.doi.org/10.17579/abstractbooksepd2022.o007.

Full text
Abstract:
Introduction. Dual diagnosis (DD) refers to the simultaneous diagnosis of a psychiatric disorder and a substance use disorder (SUD). The prevalence rate is considerably high in patients with schizophrenia and affective disorders; it predicts a more severe illness course, with decreased adherence to treatment and higher rates of hospitalization. As such, there is a growing demand for clinical guidelines and treatment consensus for these patients. In this retrospective analysis, we aimed to examine if and how prescription patterns in DD differ regarding psychiatric diagnosis and type of substance used. Methods. Data from patients with a DD diagnosis admitted at Lisbon’s Psychiatric Hospital Center from June to September 2021 was collected (n=94). Chi-square or Fisher tests were used to analyze associations between substance use and specific psychiatric disorders, along with number and class of medications prescribed. Results. Schizophrenia was the most frequent diagnosis (n=47). The most abused substances were alcohol (n=62) and cannabinoids (n=57). We found a statistically significant association between schizophrenia and cannabis misuse (p=0,006). A personality disorder diagnosis was also found to be associated to the misuse of cannabinoids (p=0,04) and cocaine (p=0,003). Finally, there was a statistically significant association between prescription of 2 or more drugs from different classes and a diagnosis of schizophrenia. No association was found between number/class of drugs, other psychiatric conditions or the type of substance misuse. Conclusion. Our study confirms well established associations between specific substance use and psychiatric conditions. However, no evidence of a specific drug prescription pattern of use in DD patient was apparent, which suggests the need for more studies on DD population and treatment outcomes.
APA, Harvard, Vancouver, ISO, and other styles
7

Nan, Wenya, Lanshin Chang, Joao Pedro Rodrigues, Feng Wan, Peng Un Mak, Pui-In Mak, Mang I. Vai, and Agostinho Rosa. "Neurofeedback for the treatment of schizophrenia: Case study." In 2012 IEEE International Conference on Virtual Environments, Human-Computer Interfaces and Measurement Systems (VECIMS). IEEE, 2012. http://dx.doi.org/10.1109/vecims.2012.6273182.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Froes Carvalho, Vera, Miguel Carneiro, Sérgio Esteves, Sandra Torres, and Zita Gameiro. "Motivational interview for schizophrenia patients and alcohol abuse." In 22° Congreso de la Sociedad Española de Patología Dual (SEPD) 2020. SEPD, 2020. http://dx.doi.org/10.17579/sepd2020o038.

Full text
Abstract:
The co-occurrence of schizophrenia and alcohol use disorders often leads to poor treatment retention and adherence. There are very few reports of efficient approaches to treat alcohol abuse in patients with schizophrenia. The purpose of this work was to review the benefits of motivational interview (MI) for alcohol disorders in patients with schizophrenia, and if it can be use in default or if there are some adaptations for this specific population. The authors did a non-systematic review of the literature with the words “motivational interview”, “schizophrenia”, “alcohol”. A case report from 2017 shows a 42 years old man in which was valued the patient's narrative and opinions with support and understanding, that lead to a increase in motivation of abstinence. Reflective listening and summarizing were very important to help with the consciousness of the disease. A study from 2007 with 60 patients shows that they tolerate the shorter sessions (20–30 min) better than longer sessions, because of the difficult time focusing for an extended period of time. More sessions are advantageous because it takes some time for patients to learn how to respond. Other study from 2003 with 30 patients shows that subjects randomized to the MI intervention had a significant reduction in drinking days and an increase in abstinence rates when compared to subjects receiving educational treatment. A blind randomised controlled trial from 2010 with 327 patients shows that integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and substance misuse does reduce the amount of substance used for at least one year after completion of therapy. In conclusion there are evidence of the use of motivational interview in patients with schizophrenia. And the improve is bigger if there is an adaptation to this specific population. More studies are still needed in this aera.
APA, Harvard, Vancouver, ISO, and other styles
9

GAEBEL, WOLFGANG. "INTERMITTENT NEUROLEPTIC LONG-TERM TREATMENT IN SCHIZOPHRENIA: STATE OF THE ART." In IX World Congress of Psychiatry. WORLD SCIENTIFIC, 1994. http://dx.doi.org/10.1142/9789814440912_0101.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Abdyrakhmanova, Aiperi, Natalia Shnayder, and Regina Nasyrova. "THE ROLE OF PHARMACOGENETIC TESTING IN TREATMENT OF SCHIZOPHRENIA: CLINICAL CASE." In XVIII INTERNATIONAL INTERDISCIPLINARY CONGRESS NEUROSCIENCE FOR MEDICINE AND PSYCHOLOGY. LCC MAKS Press, 2022. http://dx.doi.org/10.29003/m2660.sudak.ns2022-18/40.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Schizophrenics Treatment"

1

Library, Spring. Schizophrenia & the Mental Fog. Spring Library, December 2020. http://dx.doi.org/10.47496/sl.blog.18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Frank, Richard, Thomas McGuire, and Sharon-Lise Normand. Cost-Offsets of New Medications for Treatment of Schizophrenia. Cambridge, MA: National Bureau of Economic Research, October 2006. http://dx.doi.org/10.3386/w12643.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

McDonagh, Marian S., Tracy Dana, Shelley Selph, Emily B. Devine, Amy Cantor, Christina Bougatsos, Ian Blazina, et al. Treatments for Schizophrenia in Adults: A Systematic Review. Agency for Healthcare Research and Quality, 2017. http://dx.doi.org/10.23970/ahrqepccer198.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Frank, Richard, Ernst Berndt, and Alisa Busch. Quality-Constant Price Indexes for the Ongoing Treatment of Schizophrenia: An Exploratory Study. Cambridge, MA: National Bureau of Economic Research, October 2003. http://dx.doi.org/10.3386/w10022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Clark Jeffries, Clark Jeffries. Cause and treatment of schizophrenia: ultimate goals of linking the disorder with the immune system. Experiment, December 2016. http://dx.doi.org/10.18258/8782.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Steuber, Lucas. Disordered Thought, Disordered Language: A corpus-based description of the speech of individuals undergoing treatment for schizophrenia. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.63.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ye, Chong, Xin Li, Han Wen, Bin Wang, and Ning Ma. Government Policies, Hospital-Community Management and Pharmacological Treatment of Schizophrenia in China: Protocol for A Scoping Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0056.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

de Bartolomeis, Andrea, Mariateresa Ciccarelli, Giuseppe De Simone, Benedetta Mazza, Annarita Barone, and Licia Vellucci. Canonical and non-canonical antipsychotics’ molecular effects of present and next generation molecules on dopamine: translational highlights for treatment response and treatment-resistant schizophrenia. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2023. http://dx.doi.org/10.37766/inplasy2023.1.0079.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Fei, Xinxing, Shiqi Wang, Jiyang Li, Jianxiong Wang, Yaqian Gao, and Yue Hu. The efficacy and safety of sodium nitroprusside in the treatment of schizophrenia: an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2022. http://dx.doi.org/10.37766/inplasy2022.6.0040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

de Bartolomeis, Andrea, Licia Vellucci, Giuseppe De Simone, Benedetta Mazza, Annarita Barone, and Mariateresa Ciccarelli. Dysregulated signaling at postsynaptic density: a systematic review and translational appraisal for the pathophysiology, clinics, and antipsychotics’ treatment of schizophrenia. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0129.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Schizophrenics Treatment' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography